Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
HESTERBIO •NSE
Hester Biosciences
₹2,052.90-1.50 (0.07%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
2,033.30
Today’s high
2,085.00
52 week low
1,239.30
52 week high
2,350.00
Open price
2,054.40
Previous close
2,054.40
Live volume
2,590
Lower circuit
1,643.60
Upper circuit
2,465.20
Fundamentals
Market Cap
₹1,741Cr
ROE
15.45%
P/E Ratio(TTM)
30.29
EPS(TTM)
67.57
P/B Ratio
4.83
Dividend Yield
0.54%
Industry P/E
33.91
Book Value
423.47
Debt to Equity
0.54
Face Value
10
Financial performance
MAR '26
Revenue (Cr)
₹97.08
+24.32%
Profit (Cr)
₹16.55
+77.77%
0255075100
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +29% |
| 3Y CAGR | +8% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +975% |
| 3Y CAGR | -10% |
About
Hester Biosciences is one of India's leading animal healthcare companies, headquartered in Gujarat and driven by a commitment to innovation and quality. The company's vision is to build the future on a foundation of excellence in its field of work. Its guiding mission is to achieve better health for humans through healthier animals, operating under the 'One Health' framework where all well-being is interconnected. The company's business is structured into two main divisions: Poultry Healthcare and Animal Healthcare, which includes products for farm animals and pets. It offers a comprehensive portfolio of over 50 vaccines and 70 different health products to support farmers, veterinarians, and pet parents. Domestically, the company is the second-largest poultry vaccine manufacturer, commanding approximately 35% of the market share in India.;
CEO/MD
Rajiv Gandhi
Founded in
1987
NSE symbol
HESTERBIO
Shareholding Pattern
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ₹8,496.00 -7.00 (0.08%) | 21,249.25 | 113.31 | 24.35 | ||
PfizerPFIZER | ₹4,497.90 -5.20 (0.12%) | 20,597.46 | 28.51 | 4.9 | ||
₹1,409.10 +32.60 (2.37%) | 19,081.41 | 29.47 | 4.89 | |||
Granules IndiaGRANULES | ₹741.60 -6.75 (0.90%) | 18,557.51 | 31.19 | 3.65 |
Livesquawk •
Hester Biosciences recommends Rs 11/share dividend, reflecting strong shareholder returns.
The dividend announcement highlights the company's solid business performance.
Livesquawk •
Hester Biosciences Q4 revenue rose to ₹1B, up from ₹819M YoY.
This reflects strong growth for the quarter.
Livesquawk •
Hester Biosciences to sell 43.81% stake in Texas Lifesciences for ₹92M.
Texas Lifesciences will cease to be a subsidiary after the transaction.
2026
15
May
Annual Result
Release date
30
Jan
Quarterly Result
Release date
2025
12
Nov
Quarterly Result
Release date
6AugDividendEx date₹7.00per share
6
Aug
Dividend
Ex date
₹7.00
per share
For each share you hold, you will receive ₹7.00
Dividend amount₹7.00 per share
Dividend TypeFinal
Ex Date6 Aug ‘25
Record Date6 Aug ‘25
Announcement date9 May ‘25
1
Aug
Quarterly Result
Release date
9MayDividendAnnounced₹7.00per share
9
May
Dividend
Announced
₹7.00
per share
For each share you hold, you will receive ₹7.00
Dividend amount₹7.00 per share
Dividend TypeFinal
Ex Date6 Aug ‘25
Record Date6 Aug ‘25
Announcement date9 May ‘25
2024
22AugDividendEx date₹6.00per share
22
Aug
Dividend
Ex date
₹6.00
per share
For each share you hold, you will receive ₹6.00
Dividend amount₹6.00 per share
Dividend TypeFinal
Ex Date22 Aug ‘24
Record Date23 Aug ‘24
Announcement date10 May ‘24
Events calendar
View upcoming events in other stocks